Prosight Management »

Boston Scientific Corporation shares owned by Prosight Management

Quarter-by-quarter ownership of Boston Scientific Corporation (BSX) shares owned by Prosight Management from 13F filings

Historical chart of Prosight Management investment in Boston Scientific Corporation

Tip: Access up to 7 years of quarterly data

All positions including Boston Scientific Corporation held by Prosight Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Boston Scientific Corporation by Prosight Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $20M 210k 95.35
2025-09-30 $7.4M 76k 97.63

More positions owned by Prosight Management

Procept Biorobotics Corp (PRCT)
Galapagos Nv Spon Adr (GLPG)
Janux Therapeutics (JANX)
Adc Therapeutics Sa SHS (ADCT)
Kura Oncology (KURA)
Meiragtx Holdings (MGTX)
Nektar Therapeutics Com New (NKTR)
Veeva Sys Cl A Com (VEEV)
Icon SHS (ICLR)
Boston Scientific Corporation (BSX)
Concentra Group Holdings Par Common Stock (CON)
Phreesia (PHR)
Amicus Therapeutics (FOLD)
Select Medical Holdings Corporation (SEM)
Syndax Pharmaceuticals (SNDX)

View all positions for Prosight Management

Top funds holding Boston Scientific Corporation

BlackRock
Vanguard Group
FMR
State Street Corporation
Geode Capital Management
PRIMECAP Management Company
Jpmorgan Chase & Co
Capital World Investors
Norges Bank Investment Management
Bollard
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Goldman Sachs Group
UBS Group
Wellington Management Company
Northern Trust

View all funds holding Boston Scientific Corporation